CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-04 | Cui Xiangmin Director | Conversion · Series A Preferred Stock | −51,579 | 0 | ||
| 2024-09-04 | Cui Xiangmin Director | Conversion · Series A Preferred Stock | −128,792 | 0 | ||
| 2024-09-03 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +200,801 | 200,801 | ||
| 2024-09-03 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +200,801 | 200,801 | ||
| 2024-09-03 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +200,801 | 200,801 | ||
| 2024-09-03 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +200,801 | 200,801 | ||
| 2024-09-03 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Series A Preferred Stock | +25,436 | 25,436 | ||
| 2024-09-03 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Series A Preferred Stock | +16,957 | 16,957 | ||
| 2024-09-03 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Warrants (Right to Buy) | +86,471 | 86,471 | ||
| 2024-09-03 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Warrants (Right to Buy) | +57,647 | 57,647 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Series A Preferred Stock | +9,671 | 9,671 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Series A Preferred Stock | +51,579 | 51,579 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Series A Preferred Stock | +128,792 | 128,792 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Warrants (Right to Buy) | +32,877 | 32,877 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Warrants (Right to Buy) | +175,346 | 175,346 | ||
| 2024-09-03 | Cui Xiangmin Director | Grant or award · Warrants (Right to Buy) | +437,834 | 437,834 | ||
| 2024-06-25 | Cui Xiangmin Director | Purchase | +277,895 | $2.97 | $825K | 2,453,131 |
| 2024-06-24 | Cui Xiangmin Director | Purchase | +336,874 | $2.98 | $1.0M | 2,175,236 |
| 2024-06-21 | Cui Xiangmin Director | Purchase | +75,411 | $3.00 | $226K | 1,838,362 |
| 2024-06-20 | Cui Xiangmin Director | Purchase | +87,715 | $2.99 | $262K | 1,762,951 |
Page 7 of 15 · 291 trades